ILLUMINA INC (ILU.DE) Stock Fundamental Analysis
FRA:ILU - Deutsche Boerse Ag - US4523271090 - Common Stock - Currency: EUR
Overall ILU gets a fundamental rating of 5 out of 10. We evaluated ILU against 19 industry peers in the Life Sciences Tools & Services industry. ILU is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. ILU has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year ILU was profitable.
In the past year ILU had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: ILU reported negative net income in multiple years.
ILU had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of -15.61%, ILU is doing worse than 89.47% of the companies in the same industry.
ILU has a worse Return On Equity (-40.75%) than 89.47% of its industry peers.
ILU has a better Return On Invested Capital (13.57%) than 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -15.61% | ||
| ROE | -40.75% | ||
| ROIC | 13.57% |
ROA(3y)-22.28%
ROA(5y)-10.63%
ROE(3y)-46.16%
ROE(5y)-23.48%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
ILU has a better Operating Margin (21.07%) than 84.21% of its industry peers.
In the last couple of years the Operating Margin of ILU has declined.
With an excellent Gross Margin value of 66.34%, ILU belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Gross Margin of ILU has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.07% | ||
| PM (TTM) | N/A | ||
| GM | 66.34% |
OM growth 3YN/A
OM growth 5Y-11.47%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.07%
GM growth 5Y-1.23%
2. Health
2.1 Basic Checks
ILU has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for ILU remains at a similar level compared to 1 year ago.
Compared to 5 years ago, ILU has more shares outstanding
ILU has a worse debt/assets ratio than last year.
2.2 Solvency
ILU has an Altman-Z score of 3.24. This indicates that ILU is financially healthy and has little risk of bankruptcy at the moment.
ILU has a Altman-Z score (3.24) which is in line with its industry peers.
ILU has a debt to FCF ratio of 2.27. This is a good value and a sign of high solvency as ILU would need 2.27 years to pay back of all of its debts.
ILU has a better Debt to FCF ratio (2.27) than 94.74% of its industry peers.
ILU has a Debt/Equity ratio of 0.63. This is a neutral value indicating ILU is somewhat dependend on debt financing.
ILU has a Debt to Equity ratio (0.63) which is comparable to the rest of the industry.
Even though the debt/equity ratio score it not favorable for ILU, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.63 | ||
| Debt/FCF | 2.27 | ||
| Altman-Z | 3.24 |
ROIC/WACC1.32
WACC10.25%
2.3 Liquidity
A Current Ratio of 1.86 indicates that ILU should not have too much problems paying its short term obligations.
ILU has a better Current ratio (1.86) than 84.21% of its industry peers.
A Quick Ratio of 1.48 indicates that ILU should not have too much problems paying its short term obligations.
With an excellent Quick ratio value of 1.48, ILU belongs to the best of the industry, outperforming 89.47% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.86 | ||
| Quick Ratio | 1.48 |
3. Growth
3.1 Past
ILU shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 278.41%, which is quite impressive.
Measured over the past years, ILU shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -17.93% on average per year.
Looking at the last year, ILU shows a decrease in Revenue. The Revenue has decreased by -3.47% in the last year.
The Revenue has been growing slightly by 4.29% on average over the past years.
EPS 1Y (TTM)278.41%
EPS 3Y-25.65%
EPS 5Y-17.93%
EPS Q2Q%977.78%
Revenue 1Y (TTM)-3.47%
Revenue growth 3Y-1.15%
Revenue growth 5Y4.29%
Sales Q2Q%-3.25%
3.2 Future
The Earnings Per Share is expected to grow by 23.52% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 4.80% on average over the next years.
EPS Next Y76.62%
EPS Next 2Y39.83%
EPS Next 3Y30.88%
EPS Next 5Y23.52%
Revenue Next Year-2.06%
Revenue Next 2Y0.54%
Revenue Next 3Y2.28%
Revenue Next 5Y4.8%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 24.87, the valuation of ILU can be described as rather expensive.
68.42% of the companies in the same industry are more expensive than ILU, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of ILU to the average of the S&P500 Index (26.25), we can say ILU is valued inline with the index average.
ILU is valuated rather expensively with a Price/Forward Earnings ratio of 17.28.
ILU's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. ILU is cheaper than 63.16% of the companies in the same industry.
ILU is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.15, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.87 | ||
| Fwd PE | 17.28 |
4.2 Price Multiples
ILU's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. ILU is cheaper than 78.95% of the companies in the same industry.
84.21% of the companies in the same industry are more expensive than ILU, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 14.95 | ||
| EV/EBITDA | 11.17 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ILU's earnings are expected to grow with 30.88% in the coming years.
PEG (NY)0.32
PEG (5Y)N/A
EPS Next 2Y39.83%
EPS Next 3Y30.88%
5. Dividend
5.1 Amount
No dividends for ILU!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:ILU (5/28/2025, 7:00:00 PM)
73.36
+1.09 (+1.51%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners104.43%
Inst Owner ChangeN/A
Ins Owners0.14%
Ins Owner ChangeN/A
Market Cap11.61B
Analysts73.55
Price Target102.89 (40.25%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3.22%
Min EPS beat(2)-7.76%
Max EPS beat(2)1.33%
EPS beat(4)2
Avg EPS beat(4)-10.12%
Min EPS beat(4)-60.91%
Max EPS beat(4)26.88%
EPS beat(8)6
Avg EPS beat(8)314.25%
EPS beat(12)9
Avg EPS beat(12)229.49%
EPS beat(16)13
Avg EPS beat(16)180.02%
Revenue beat(2)0
Avg Revenue beat(2)-0.57%
Min Revenue beat(2)-0.95%
Max Revenue beat(2)-0.18%
Revenue beat(4)1
Avg Revenue beat(4)-0.53%
Min Revenue beat(4)-1.91%
Max Revenue beat(4)0.91%
Revenue beat(8)3
Avg Revenue beat(8)-0.59%
Revenue beat(12)4
Avg Revenue beat(12)-1.16%
Revenue beat(16)7
Avg Revenue beat(16)0.05%
PT rev (1m)-15.06%
PT rev (3m)-33.9%
EPS NQ rev (1m)-7.89%
EPS NQ rev (3m)-9.21%
EPS NY rev (1m)-4.79%
EPS NY rev (3m)-6.2%
Revenue NQ rev (1m)-1.02%
Revenue NQ rev (3m)-2.37%
Revenue NY rev (1m)-1.19%
Revenue NY rev (3m)-2.59%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.87 | ||
| Fwd PE | 17.28 | ||
| P/S | 3.02 | ||
| P/FCF | 14.95 | ||
| P/OCF | 13.1 | ||
| P/B | 5.53 | ||
| P/tB | 13.41 | ||
| EV/EBITDA | 11.17 |
EPS(TTM)2.95
EY4.02%
EPS(NY)4.25
Fwd EY5.79%
FCF(TTM)4.91
FCFY6.69%
OCF(TTM)5.6
OCFY7.63%
SpS24.29
BVpS13.26
TBVpS5.47
PEG (NY)0.32
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -15.61% | ||
| ROE | -40.75% | ||
| ROCE | 19.27% | ||
| ROIC | 13.57% | ||
| ROICexc | 18.36% | ||
| ROICexgc | 30.44% | ||
| OM | 21.07% | ||
| PM (TTM) | N/A | ||
| GM | 66.34% | ||
| FCFM | 20.2% |
ROA(3y)-22.28%
ROA(5y)-10.63%
ROE(3y)-46.16%
ROE(5y)-23.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-6.48%
ROICexc growth 3YN/A
ROICexc growth 5Y-9.28%
OM growth 3YN/A
OM growth 5Y-11.47%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.07%
GM growth 5Y-1.23%
F-Score6
Asset Turnover0.7
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.63 | ||
| Debt/FCF | 2.27 | ||
| Debt/EBITDA | 1.21 | ||
| Cap/Depr | 39.37% | ||
| Cap/Sales | 2.86% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 81.37% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.86 | ||
| Quick Ratio | 1.48 | ||
| Altman-Z | 3.24 |
F-Score6
WACC10.25%
ROIC/WACC1.32
Cap/Depr(3y)66.6%
Cap/Depr(5y)76.75%
Cap/Sales(3y)5.82%
Cap/Sales(5y)5.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)278.41%
EPS 3Y-25.65%
EPS 5Y-17.93%
EPS Q2Q%977.78%
EPS Next Y76.62%
EPS Next 2Y39.83%
EPS Next 3Y30.88%
EPS Next 5Y23.52%
Revenue 1Y (TTM)-3.47%
Revenue growth 3Y-1.15%
Revenue growth 5Y4.29%
Sales Q2Q%-3.25%
Revenue Next Year-2.06%
Revenue Next 2Y0.54%
Revenue Next 3Y2.28%
Revenue Next 5Y4.8%
EBIT growth 1Y1675.86%
EBIT growth 3YN/A
EBIT growth 5Y-7.67%
EBIT Next Year26.49%
EBIT Next 3Y15.01%
EBIT Next 5Y16.87%
FCF growth 1Y484.21%
FCF growth 3Y28.14%
FCF growth 5Y-3.38%
OCF growth 1Y334.78%
OCF growth 3Y15.37%
OCF growth 5Y-4.45%